Trials / Completed
CompletedNCT00338507
Phase 2 Study - Erdosteine in Patients With CB/COPD
A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Dose_Ranging Study of Erdosteine for the Treatment of Stable Chronic Bronchitis Associated With Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 400 (planned)
- Sponsor
- Adams Respiratory Therapeutics · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This clinical study is designed to explore dose ranging and identify methods to demonstrate the efficacy of Erdosteine in patients with stable Chronic Bronchitis associated with Chronic Obstructive Pulmonary Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Erdosteine |
Timeline
- Start date
- 2006-03-01
- First posted
- 2006-06-20
- Last updated
- 2007-12-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00338507. Inclusion in this directory is not an endorsement.